Carrhae Capital LLP acquired a new stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the third quarter, Holdings Channel reports. The fund acquired 96,215 shares of the semiconductor company’s stock, valued at approximately $47,472,000. Synopsys accounts for approximately 2.8% of Carrhae Capital LLP’s investment portfolio, making the stock its 12th largest position.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in SNPS. Alpine Bank Wealth Management lifted its stake in shares of Synopsys by 89.3% in the third quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock worth $26,000 after buying an additional 25 shares in the last quarter. TFC Financial Management Inc. grew its stake in Synopsys by 1,250.0% during the 3rd quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock valued at $27,000 after acquiring an additional 50 shares in the last quarter. Millstone Evans Group LLC purchased a new stake in Synopsys during the 3rd quarter valued at about $27,000. SOA Wealth Advisors LLC. acquired a new stake in Synopsys in the 3rd quarter valued at about $28,000. Finally, McIlrath & Eck LLC purchased a new position in Synopsys in the 3rd quarter worth approximately $29,000. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Trading Up 0.8%
SNPS opened at $429.29 on Wednesday. Synopsys, Inc. has a one year low of $365.74 and a one year high of $651.73. The stock has a market capitalization of $82.23 billion, a PE ratio of 66.66, a P/E/G ratio of 3.47 and a beta of 1.15. The business’s 50 day moving average price is $458.97 and its 200 day moving average price is $460.13. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.26 and a current ratio of 1.36.
Analyst Ratings Changes
Several research analysts have recently weighed in on the company. Morgan Stanley restated an “equal weight” rating and set a $480.00 target price (down from $550.00) on shares of Synopsys in a report on Wednesday, February 25th. Wall Street Zen upgraded Synopsys from a “sell” rating to a “hold” rating in a research report on Saturday, December 13th. Rosenblatt Securities lowered their price objective on Synopsys from $560.00 to $530.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. HSBC cut Synopsys from a “buy” rating to a “hold” rating and set a $455.00 target price for the company. in a report on Friday, February 20th. Finally, Needham & Company LLC reaffirmed a “buy” rating on shares of Synopsys in a research note on Thursday, February 26th. Eight analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Synopsys has an average rating of “Hold” and an average price target of $531.00.
Get Our Latest Analysis on Synopsys
Insider Transactions at Synopsys
In related news, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the sale, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This trade represents a 17.01% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Janet Lee sold 250 shares of the business’s stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the sale, the insider owned 11,959 shares in the company, valued at approximately $6,338,270. This trade represents a 2.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 4,157 shares of company stock valued at $1,945,036 over the last three months. Corporate insiders own 0.56% of the company’s stock.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
